Phoenix Local Business
Thursday, November 12, 2015
FDA Approves Roche's Cotellic for Combination Melanoma Therapy
(MedPage Today) -- Effective in BRAF V600 mutation-positive disease
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment